Operating Income: The income after operating expenses.
Arch Therapeutics, Inc. (ARTHQ) had Operating Income of $-5.04M for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
$0.08M |
|
$-6.98M |
|
$0.08M |
|
$-0.00M |
|
$5.12M |
|
|
Operating Income |
$-5.04M |
$-1.94M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-5.04M |
|
$-5.04M |
|
3.07M |
|
3.07M |
|
$-2.27 |
|
$-2.27 |
|
| Balance Sheet Financials | |
$1.95M |
|
$0.00M |
|
$0.01M |
|
$1.96M |
|
$9.47M |
|
-- |
|
-- |
|
$9.47M |
|
$-7.51M |
|
$-7.51M |
|
$-7.51M |
|
4.69M |
|
| Cash Flow Statement Financials | |
$-3.37M |
|
$-0.00M |
|
$2.85M |
|
$0.75M |
|
$0.22M |
|
$-0.52M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.21 |
|
-- |
|
-- |
|
-- |
|
-0.75 |
|
-3.22% |
|
-6661.67% |
|
-6661.67% |
|
-6659.07% |
|
-9221.43% |
|
-9221.43% |
|
$-3.38M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.06 |
|
-- |
|
-- |
|
93.01% |
|
93.01% |
|
-356.60% |
|
93.01% |
|
$-1.60 |
|
$-1.10 |
|
$-1.10 |
|